Eliquis 2023 sales?

How much did Eliquis sell in 2023?

Eliquis (apixaban) is one of Bristol Myers Squibb (BMS) and Pfizer’s biggest medicines. However, the exact 2023 sales figure isn’t included in the information provided here, so I can’t state a specific number without a sales source.

What companies typically report as “Eliquis sales”?

Depending on the filing or article, “Eliquis 2023 sales” usually refers to one of these:
- Net product sales reported by the manufacturer(s) (often within quarterly/annual earnings materials).
- Worldwide sales for the branded medicine across all indications.
- Revenue share by territory or by partner (in markets where BMS and Pfizer have different responsibilities).

If you want the number, which sales metric do you need?

To give the exact 2023 figure, tell me which one you’re looking for:
- BMS reported net product sales for Eliquis in 2023 (worldwide or U.S.)
- Pfizer-reported numbers (if shown separately)
- Total worldwide market sales (sometimes differs from company-reported figures)

If you share the source link you’re using (or whether you want BMS, Pfizer, or “worldwide market sales”), I can help pinpoint the correct 2023 value and interpret it.